Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 7NIH 4INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 8Neoplasm Metastasis 5Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumor 3Stomach Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Glioblastoma 2Sarcoma 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Hypertension 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1Colonic Neoplasms 1Choriocarcinoma 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Advanced Tumor 1Advanced Solid Malignancies 1Advanced Prostate Adenocarcinoma 1Advanced Breast Cancer 1

Interventions

Paclitaxel 113Carboplatin 99Bevacizumab 59pembrolizumab 56liposomal doxorubicin 56Gemcitabine 42olaparib 39Topotecan 33niraparib 29Nivolumab 21Cisplatin 21Doxorubicin 17Cyclophosphamide 171-dodecylpyridoxal 16Drug Therapy 15Docetaxel 15avelumab 13Fulvestrant 11oregovomab 10Oxaliplatin 10rucaparib 9fludarabine 9Injections 9Fluorouracil 9veliparib 8mirvetuximab soravtansine 8atezolizumab 8Cetuximab 8fluzoparib 7cemiplimab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Ovarian Neoplasms × cediranib × Clear all
NCT02889900 2022-03-08

CONCERTO

AstraZeneca

Phase 2 Completed
62 enrolled 15 charts
Gynecologic

Ovarian Neoplasms

NCT00475956 2010-04-15

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

AstraZeneca

Phase 1 Completed
40 enrolled
BreastGastrointestinalGynecologicPlasma cellThoracic

Breast Neoplasms, Choriocarcinoma, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡